EnteroMedics Inc. (NASDAQ:ETRM) registered a 33.23% increase, still its new closing price is 20850.00% up from the company’s 1 year high of 30.41.It posted 14.17% gains in previous 5 sessions and is now the subject of 0 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 1 buy or better ratings. The 1 stock analysts following this company have an average price target at $140.00, with individual PT in the $140.00-$140.00 range. The shares moved at $8.38, implying that brokerage firms see shares gaining about 874.42% in twelve months time.
EnteroMedics Inc. (ETRM) SEC Form 4 News
The stock is getting much attention these days as insiders are adding shares while they posted a 319.00% rise year to date. A SVP, Ops & Bus Dev at EnteroMedics Inc. (ETRM) acquired shares in a transaction closed on Friday June 03, 2016. DeLange Peter M. bought 286 shares in the company at $38.5 each and collected $11,000 in proceeds. DeLange Peter M. now owns 393 shares in the company after this transaction. A CEO in the company, GLADNEY DAN W, disclosed a transaction on Thursday November 12, 2015 that ended up paying $135,000 from the purchase of 714 shares at $189 per share.
EnteroMedics Inc. (NASDAQ:ETRM) Upcoming Results on Tap
EnteroMedics Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $-35.00 in that period. Sales during the quarter are predicted to arrive at $1.
Earnings surprise history: Last quarter, the company posted approximately $0 in revenue and EPS of $-11.90. The mean forecast was for $0 and $-34.65 a share, respectively. One quarter earlier, revenue for the stock was at $0, with earnings at $-34.30/share.
EnteroMedics Inc. (ETRM) Brokerage Update
EnteroMedics Inc. (ETRM) is in ROTH Capital’s research list so their analyst rating change is noteworthy. These shares were downgraded to Neutral from Buy by ROTH Capital, according to news reported on Thursday June 09, 2016.Another important research note was issued by Argus on Friday January 09, 2009.The firm downgraded ETRM to Sell from Hold. Over the last six months and over the last three months, the shares of EnteroMedics Inc. (ETRM), have changed 4310.53% and 9984.24%, respectively.